Inactive Instrument
Merrimack Pharmaceuticals Stock
Stocks
MACK
US5903282094
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 74 | 2019-06-27 |
Timothy Surgenor
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Crocker
CHM | Chairman | 74 | 2004-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/26/23 | Western Standard LLC
| Buy | Company | 49,550 | 0.3460% | |
| 12/7/23 | Western Standard LLC
| Buy | Company | 101,050 | 0.7056% | |
| 11/17/23 | Western Standard LLC
| Buy | Company | 300 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.20% | - | - | 224M | ||
| -1.34% | -4.12% | +53.70% | +68.83% | 66.37B | ||
| +0.59% | -0.56% | +8.46% | +90.01% | 58.86B | ||
| +0.54% | +0.85% | +23.58% | +87.77% | 55.22B | ||
| -2.34% | -3.90% | +10.90% | +114.82% | 47.21B | ||
| +0.09% | -6.08% | +18.67% | +25.60% | 42.45B | ||
| -2.58% | +2.22% | +14.73% | +41.28% | 36.44B | ||
| -1.76% | -11.56% | +126.44% | +635.48% | 35.19B | ||
| -0.17% | -2.37% | +76.97% | +57.69% | 32.66B | ||
| -1.69% | -0.79% | -40.58% | +386.60% | 26.73B | ||
| Average | -0.88% | -2.98% | +32.54% | +167.56% | 45B | |
| Weighted average by Cap. | -0.85% | -2.92% | +32.62% | +142.86% |
Employees
27
















